| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -559,279 | 100% | $40.92 | -$22,887,043 |
| Net | -8 | -559,279 | -100% | -$22,887,043 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James P. Mackin | President & CEO | $35,783,881 | -$8,224,640 | -19% | 02 Mar 2026 |
| John E. Davis | Chief Commercial Officer | $8,718,381 | -$2,217,656 | -20% | 02 Mar 2026 |
| Lance A. Berry | EVP, COO, CFO & Treasurer | $7,964,116 | -$782,793 | -8.9% | 02 Mar 2026 |
| Jean F. Holloway | SVP, General Counsel | $7,033,610 | -$4,499,793 | -39% | 02 Mar 2026 |
| David Ashley Lee | Executive VP, COO & CFO | $6,655,986 | 01 Mar 2023 | ||
| Amy Horton | VP, Chief Accounting Officer | $5,254,132 | -$1,177,676 | -18% | 02 Mar 2026 |
| Daniel J. Bevevino | Director | $3,577,454 | 22 May 2025 | ||
| Thomas F. Ackerman | Director | $3,573,520 | 22 May 2025 | ||
| Jon W. Salveson | Director | $3,095,385 | 22 May 2025 | ||
| Marshall S. Stanton | SVP, Clinical & MD Affair | $2,270,200 | -$5,721,047 | -72% | 02 Mar 2026 |
| Ronald D. McCall | Director | $2,191,824 | 25 Aug 2021 | ||
| Harvey Morgan | Director | $1,747,980 | 30 Aug 2021 | ||
| James Bullock | Director | $1,636,544 | 22 May 2025 | ||
| Jeffrey H. Burbank | Director | $1,282,496 | 22 May 2025 | ||
| Elizabeth A. Hoff | Director | $1,226,169 | -$189,412 | -13% | 18 Nov 2025 |
| Marna P. Borgstrom | Director | $1,170,257 | 22 May 2025 | ||
| Anthony B. Semedo | Director | $1,121,341 | -$74,027 | -6.2% | 23 May 2025 |
| Andrew M. Green | VP Regulatory | $1,005,090 | 04 Dec 2024 | ||
| Rochelle L. Maney | VP, Quality | $871,883 | 01 Mar 2024 | ||
| Matthew A. Getz | VP, Human Resources | $863,527 | 16 Aug 2024 | ||
| Dennis B. Maier | SVP, Operations | $625,032 | 06 Jun 2023 | ||
| Florian Tyrs | VP, Global Operations | $586,120 | 27 Feb 2024 | ||
| Franz Peter Barthold | VP, Research & Development | $585,288 | 08 Nov 2022 | ||
| Robert C. Thomson | VP Research & Development | $250,735 | 23 Feb 2024 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jean F. Holloway | AORT | Common Stock | Sale | -4.62% | $340,556 | $38.00 | -8,962 | 185,095 | 04 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Sale | -0.64% | $34,036 | $37.78 | -901 | 139,088 | 03 Mar 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -1.94% | $145,172 | $37.78 | -3,843 | 194,057 | 03 Mar 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -3.45% | $81,180 | $37.78 | -2,149 | 60,097 | 03 Mar 2026 | Direct |
| John E. Davis | AORT | Common Stock | Sale | -1.94% | $172,748 | $37.78 | -4,573 | 230,794 | 03 Mar 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -2.91% | $238,591 | $37.78 | -6,316 | 210,827 | 03 Mar 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -1.85% | $675,692 | $37.78 | -17,887 | 947,275 | 03 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Award | 5.64% | 7,475 | 139,989 | 02 Mar 2026 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Award | 16.3% | 27,795 | 197,900 | 02 Mar 2026 | Direct | ||
| Marshall S. Stanton | AORT | Common Stock | Award | 54% | 21,838 | 62,246 | 02 Mar 2026 | Direct | ||
| John E. Davis | AORT | Common Stock | Award | 14% | 28,845 | 235,367 | 02 Mar 2026 | Direct | ||
| Lance A. Berry | AORT | Common Stock | Award | 23.2% | 40,874 | 217,143 | 02 Mar 2026 | Direct | ||
| James P. Mackin | AORT | Common Stock | Award | 13.8% | 116,948 | 965,162 | 02 Mar 2026 | Direct | ||
| Amy Horton | AORT | Common Stock | Sale | -0.48% | $24,374 | $38.02 | -641 | 132,514 | 02 Mar 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -3.61% | $57,532 | $38.02 | -1,513 | 40,408 | 02 Mar 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -1.73% | $566,989 | $38.02 | -14,911 | 848,214 | 02 Mar 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -1.27% | $83,008 | $38.02 | -2,183 | 170,105 | 02 Mar 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -2.85% | $196,893 | $38.02 | -5,178 | 176,269 | 02 Mar 2026 | Direct |
| John E. Davis | AORT | Common Stock | Sale | -1.33% | $105,861 | $38.02 | -2,784 | 206,522 | 02 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Award | 4.44% | 5,658 | 133,155 | 24 Feb 2026 | Direct | ||
| Amy Horton | AORT | Common Stock | Sale | -0.65% | $29,625 | $35.69 | -830 | 127,497 | 24 Feb 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -2.92% | $44,937 | $35.69 | -1,259 | 41,921 | 24 Feb 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Award | 13.2% | 20,085 | 172,288 | 24 Feb 2026 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Sale | -1.08% | $59,536 | $35.69 | -1,668 | 152,203 | 24 Feb 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Award | 12.7% | 97,030 | 863,125 | 24 Feb 2026 | Direct | ||
| James P. Mackin | AORT | Common Stock | Sale | -1.79% | $497,418 | $35.69 | -13,936 | 766,095 | 24 Feb 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Award | 26% | 37,482 | 181,447 | 24 Feb 2026 | Direct | ||
| Lance A. Berry | AORT | Common Stock | Sale | -3.02% | $160,083 | $35.69 | -4,485 | 143,965 | 24 Feb 2026 | Direct |
| John E. Davis | AORT | Common Stock | Award | 10.8% | 20,438 | 209,306 | 24 Feb 2026 | Direct | ||
| John E. Davis | AORT | Common Stock | Sale | -1.09% | $74,063 | $35.69 | -2,075 | 188,868 | 24 Feb 2026 | Direct |
| Amy Horton | AORT | Common Stock | Sale | -1.33% | $65,065 | $37.59 | -1,731 | 128,327 | 23 Feb 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -5.31% | $91,076 | $37.59 | -2,423 | 43,180 | 23 Feb 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -1.96% | $115,733 | $37.59 | -3,079 | 153,871 | 23 Feb 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -2.62% | $787,920 | $37.59 | -20,962 | 780,031 | 23 Feb 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -3.25% | $187,226 | $37.59 | -4,981 | 148,450 | 23 Feb 2026 | Direct |
| John E. Davis | AORT | Common Stock | Sale | -1.94% | $141,820 | $37.59 | -3,773 | 190,943 | 23 Feb 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Award | 0.7% | 316 | 45,603 | 31 Dec 2025 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Award | 0.15% | 228 | 156,950 | 31 Dec 2025 | Direct | ||
| John E. Davis | AORT | Common Stock | Sale | -2.51% | $225,550 | $45.11 | -5,000 | 193,842 | 15 Dec 2025 | Direct |
| Amy Horton | AORT | Common Stock | Sale | -3.4% | $203,084 | $44.42 | -4,572 | 130,058 | 08 Dec 2025 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -3.72% | $1,405,700 | $45.46 | -30,921 | 800,993 | 03 Dec 2025 | Direct |
| James P. Mackin | AORT | Common Stock | Options Exercise | 3.86% | 30,921 | 831,914 | 03 Dec 2025 | Direct | ||
| James P. Mackin | AORT | Stock Options (Right to buy) | Options Exercise | -100% | -30,921 | 0 | 03 Dec 2025 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Sale | -4.48% | $331,370 | $45.30 | -7,315 | 156,093 | 03 Dec 2025 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -3.72% | $1,408,730 | $45.56 | -30,921 | 800,993 | 02 Dec 2025 | Direct |
| James P. Mackin | AORT | Common Stock | Options Exercise | 3.86% | 30,921 | 831,914 | 02 Dec 2025 | Direct | ||
| James P. Mackin | AORT | Stock Options (Right to buy) | Options Exercise | -100% | -30,921 | 0 | 02 Dec 2025 | Direct | ||
| Amy Horton | AORT | Common Stock | Gift | -0.55% | -750 | 134,630 | 01 Dec 2025 | Direct | ||
| Marshall S. Stanton | AORT | Common Stock | Sale | -51.4% | $2,133,920 | $45.04 | -47,376 | 44,753 | 21 Nov 2025 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Options Exercise | 193.8% | 47,376 | 71,828 | 21 Nov 2025 | Direct |